After a mean follow-up of 6.5 years (range 3–9 years), the DCCT reported clinically and statistically highly significant reductions (range of 35–>70%) in microvascular end points in the intensive compared with the conventional therapy group.
← all excerpts
Inflammation and progressive nephropathy in type 1 diabetes in the diabetes control and complications trial.
1
—
—